DE69622074D1 - Cystin-Silikon-Copolymere und deren Verwendung zur Behandlung von keratinischen Materialien - Google Patents

Cystin-Silikon-Copolymere und deren Verwendung zur Behandlung von keratinischen Materialien

Info

Publication number
DE69622074D1
DE69622074D1 DE69622074T DE69622074T DE69622074D1 DE 69622074 D1 DE69622074 D1 DE 69622074D1 DE 69622074 T DE69622074 T DE 69622074T DE 69622074 T DE69622074 T DE 69622074T DE 69622074 D1 DE69622074 D1 DE 69622074D1
Authority
DE
Germany
Prior art keywords
cystine
treatment
silicone copolymers
keratinous materials
keratinous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69622074T
Other languages
English (en)
Other versions
DE69622074T2 (de
Inventor
Roger Trevor Jones
Surinder Pall Chahal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Croda International PLC
Original Assignee
Croda International PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Croda International PLC filed Critical Croda International PLC
Publication of DE69622074D1 publication Critical patent/DE69622074D1/de
Application granted granted Critical
Publication of DE69622074T2 publication Critical patent/DE69622074T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/896—Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate
    • A61K8/899—Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate containing sulfur, e.g. sodium PG-propyldimethicone thiosulfate copolyol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/04—Preparations for permanent waving or straightening the hair
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/48—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule in which at least two but not all the silicon atoms are connected by linkages other than oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/48—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule in which at least two but not all the silicon atoms are connected by linkages other than oxygen atoms
    • C08G77/54—Nitrogen-containing linkages
    • D—TEXTILES; PAPER
    • D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M15/00—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment
    • D06M15/19—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment with synthetic macromolecular compounds
    • D06M15/37—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • D06M15/643—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds containing silicon in the main chain
    • D—TEXTILES; PAPER
    • D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M15/00—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment
    • D06M15/19—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment with synthetic macromolecular compounds
    • D06M15/37—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • D06M15/643—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds containing silicon in the main chain
    • D06M15/6436—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds containing silicon in the main chain containing amino groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Textile Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Silicon Polymers (AREA)
DE69622074T 1995-04-04 1996-04-04 Cystin-Silikon-Copolymere und deren Verwendung zur Behandlung von keratinischen Materialien Expired - Lifetime DE69622074T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9506926.6A GB9506926D0 (en) 1995-04-04 1995-04-04 Cystine-siicone copolymers and their use for treating keratin substrates

Publications (2)

Publication Number Publication Date
DE69622074D1 true DE69622074D1 (de) 2002-08-08
DE69622074T2 DE69622074T2 (de) 2003-03-27

Family

ID=10772475

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69622074T Expired - Lifetime DE69622074T2 (de) 1995-04-04 1996-04-04 Cystin-Silikon-Copolymere und deren Verwendung zur Behandlung von keratinischen Materialien

Country Status (4)

Country Link
US (1) US5679819A (de)
EP (1) EP0736297B1 (de)
DE (1) DE69622074T2 (de)
GB (1) GB9506926D0 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772771B1 (fr) * 1997-12-19 2000-01-28 Oreal Utilisation de polymeres hyperbranches et de dendrimeres comportant un groupement particulier, en tant qu'agent filmogene, les compositions filmogenes les comprenant et leur utilisation notamment en cosmetique ou en pharmacie
FR2772770B1 (fr) * 1997-12-19 2000-01-28 Oreal Nouveaux composes choisis parmi les polymeres hyperbranches et les dendrimeres ayant un groupement particulier, procede de preparation, utilisation et compositions les comprenant
DE19848002A1 (de) * 1998-10-17 2000-04-20 Goldschmidt Ag Th Polypeptid-Polysiloxan-Copolymere
JP2000191792A (ja) * 1998-12-25 2000-07-11 Seiwa Kasei:Kk ポリシロキサン粒子
EP1102784A4 (de) * 1999-06-07 2009-12-30 Mirus Bio Corp Eine verbindung mit einer labilen disulfid-bindung
US6270791B1 (en) * 1999-06-11 2001-08-07 Keraplast Technologies, Ltd. Soluble keratin peptide
US6783546B2 (en) 1999-09-13 2004-08-31 Keraplast Technologies, Ltd. Implantable prosthetic or tissue expanding device
US6371984B1 (en) 1999-09-13 2002-04-16 Keraplast Technologies, Ltd. Implantable prosthetic or tissue expanding device
US6544548B1 (en) * 1999-09-13 2003-04-08 Keraplast Technologies, Ltd. Keratin-based powders and hydrogel for pharmaceutical applications
DE10036522A1 (de) * 2000-07-27 2002-02-21 Ge Bayer Silicones Gmbh & Co Lineare aminosäuremodifizierte polyquarternäre Polysiloxana
DE10036532A1 (de) * 2000-07-27 2002-02-21 Ge Bayer Silicones Gmbh & Co alpha.w-aminosäurefunktionalisierte Polysiloxane
KR100857630B1 (ko) 2001-08-06 2008-09-08 사우쓰웨스트 리서치 인스티튜트 촉매 변환기 내구성을 테스트하는 방법 및 장치
WO2003035722A1 (en) * 2001-09-25 2003-05-01 Southwest Research Institute Methods for controlling peptide solubility, chemically modified peptides, and stable solvent systems for producing same
EP1478328B1 (de) * 2002-01-28 2013-06-05 Keraplast Technologies Ltd. Bioaktive keratinpeptide
AU2007211894B2 (en) * 2002-03-14 2009-07-30 Croda International Plc Protein-Silane/Siloxane Copolymers, their Preparation and their Use
GB0206048D0 (en) * 2002-03-14 2002-04-24 Croda Int Plc Use
US7001987B2 (en) * 2002-04-22 2006-02-21 Keraplast Technologies, Ltd. Hydrogel with controllable mechanical, chemical, and biological properties and method for making same
US6914126B2 (en) * 2002-04-10 2005-07-05 Keraplast Technologies, Ltd. Methods for producing, films comprising, and methods for using heterogenous crosslinked protein networks
US20040120910A1 (en) * 2002-04-10 2004-06-24 Dyke Mark Van Methods for producing, films comprising, and methods for using heterogeneous crosslinked protein networks
US6989437B2 (en) 2002-04-10 2006-01-24 Keraplast Technologies, Ltd. Methods for producing, films comprising, and methods for using heterogeneous crosslinked protein networks
US20040082717A1 (en) * 2002-06-24 2004-04-29 Southwest Research Institute Keratin-silicone copolymers and interpenetrating networks (IPN's), methods of production and methods of use thereof
US20040062793A1 (en) * 2002-07-05 2004-04-01 Dyke Mark Van Tissue defect dressings comprising proteinaceous networks
US7163321B2 (en) * 2002-07-25 2007-01-16 Steven Contarino Emergency vehicle grille
WO2007001339A2 (en) 2004-08-17 2007-01-04 Wake Forest University Health Sciences Ambient stored blood plasma expanders
US8920827B2 (en) * 2005-10-21 2014-12-30 Wake Forest University Health Sciences Keratin bioceramic compositions
US7892573B2 (en) 2006-02-10 2011-02-22 Wake Forest University Health Sciences Nerve regeneration employing keratin biomaterials
JP2009527274A (ja) 2006-02-17 2009-07-30 ウェイク・フォレスト・ユニヴァーシティ・ヘルス・サイエンシズ ケラチン医用生体材料から形成されるコーティングおよび生体用インプラント
US8273702B2 (en) * 2006-02-17 2012-09-25 Wake Forest University Health Sciences Wound healing compositions containing keratin biomaterials
GB0611217D0 (en) * 2006-06-08 2006-07-19 Dow Corning Amino-acid functional siloxanes,methods of preparation and applications
US20090047260A1 (en) * 2007-08-17 2009-02-19 Wake Forest University Health Sciences Keratin biomaterials for cell culture and methods of use
US9068162B2 (en) 2007-08-17 2015-06-30 Wake Forest University Health Sciences Keratin biomaterials for cell culture and methods of use
JP5383035B2 (ja) * 2007-12-27 2014-01-08 東レ・ダウコーニング株式会社 アミノ酸変性オルガノポリシロキサンエマルジョンの製造方法
EP2542564B1 (de) * 2010-03-05 2018-05-09 Wake Forest University Health Sciences System für gesteuerte freisetzung
WO2011112575A1 (en) * 2010-03-08 2011-09-15 Wake Forest University Health Sciences Keratin biomaterials for treatment of ischemia
AU2011329839B2 (en) 2010-11-17 2016-12-08 Wake Forest University Health Sciences Keratin compositions for treatment of bone deficiency or injury
WO2013025928A2 (en) 2011-08-17 2013-02-21 Keranetics Llc Methods for extracting keratin proteins
EP2744480B8 (de) 2011-08-17 2019-06-26 Keratin Biosciences, Inc. Proteinarme gelierungszusammensetzungen
DE102011085492A1 (de) 2011-10-31 2013-05-02 Evonik Goldschmidt Gmbh Neue aminogruppenhaltige Siloxane, Verfahren zu deren Herstellung und Anwendung
US9827245B2 (en) 2013-03-15 2017-11-28 KeraNetics, LLC Keratin compositions comprising halofuginone
DE102015210171A1 (de) * 2015-06-02 2016-12-08 Wacker Chemie Ag Aminosäure-Gruppierungen aufweisende Organosiliciumverbindungen und Verfahren zu ihrer Herstellung
EP3178523B1 (de) 2015-12-08 2019-03-13 MAG Cosmetics GmbH Haarbehandlungsmittel, insbesondere haarpflegemittel, sowie dessen verwendung
CN110099672B (zh) 2016-12-21 2022-05-24 联合利华知识产权控股有限公司 具有氨基酸和烟酰胺化合物的局部皮肤增亮添加剂和组合物
EP3558244B1 (de) 2016-12-21 2022-02-23 Unilever IP Holdings B.V. Körperpflegezusammensetzungen mit cystin
US11260005B2 (en) 2016-12-21 2022-03-01 Conopco, Inc. Personal care compositions with glutathione precursor comprising 4-substituted resorcinols and amino acids
EP3558243B1 (de) * 2016-12-21 2022-10-05 Unilever IP Holdings B.V. Körperpflegezusammensetzungen mit schwerlöslichen verbindungen
CN110461302A (zh) * 2017-03-28 2019-11-15 禾大国际股份公开有限公司 头发造型材料
ES2919427T3 (es) 2017-07-18 2022-07-26 Basf Se Un polímero para el tratamiento del cabello
KR101989888B1 (ko) * 2017-12-27 2019-06-17 동성제약주식회사 손상된 모발의 복구를 위한 시스틴-실리콘 공중합체를 함유하는 모발 보호제 조성물 및 이를 포함하는 염모제
BR112022021257A2 (pt) 2020-04-23 2022-12-06 Basf Se Polímero, composição adequada para uso como uma formulação cosmética, uso do polímero ou da composição, e, processo para tratar cabelo humano ou animal
WO2022169633A1 (en) 2021-02-02 2022-08-11 Federici Brands, Llc Composition comprising a hydrolyzed keratin and a silane crosslinking agent and process for hair protection during bleaching

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4113696A (en) * 1977-06-28 1978-09-12 Union Carbide Corporation Polysulfide silicon compounds
JP2573007B2 (ja) * 1987-12-28 1997-01-16 株式会社成和化成 修飾された動物毛粉末
US5068378A (en) * 1990-01-09 1991-11-26 Dow Corning Corporation Thioglycolamide-functional siloxanes
US5085858A (en) * 1990-01-09 1992-02-04 Dow Corning Corporation Thioglycolamide-functional siloxanes
DE4109869C1 (de) * 1991-03-26 1992-09-24 Th. Goldschmidt Ag, 4300 Essen, De
GB9123251D0 (en) * 1991-11-01 1991-12-18 Croda Int Plc Protein-silicone copolymers
JPH05339132A (ja) * 1992-06-10 1993-12-21 Pola Chem Ind Inc 毛髪化粧料及び毛髪の処理方法

Also Published As

Publication number Publication date
EP0736297A2 (de) 1996-10-09
US5679819A (en) 1997-10-21
EP0736297A3 (de) 1997-05-07
GB9506926D0 (en) 1995-05-24
DE69622074T2 (de) 2003-03-27
EP0736297B1 (de) 2002-07-03

Similar Documents

Publication Publication Date Title
DE69622074T2 (de) Cystin-Silikon-Copolymere und deren Verwendung zur Behandlung von keratinischen Materialien
DE69836752D1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
DE69830728D1 (de) Arzneimittel zur behandlung von häufigem wasserlassen und harninkontinenz
DE69332732D1 (de) Pharmazeutische Zusammensetzung und Methode zur Behandlung von Hyperlipidämie und Arterioskerose
DE69739758D1 (de) Vakzine zur behandlung von lymphomen und leukämie
ATE438397T1 (de) Pharmazeutische zubereitung enthaltend pioglitazone und glimepiride zur verwendung in der behandlung von diabetes
DE69729284D1 (de) Filmbildende zusammensetzungen von antihyperalgesischen opiaten und deren verwendung zur behandlung von hyperalgesie
ATE260652T1 (de) Arzneimittel und verfahren zur behandlung von aufmerksamkeitsstörungen und aufmerksamkeits- /hyperaktivitätsstörungen mit methylphenidat
DE69115921D1 (de) Verfahren zur behandlung und verwendung von abfallstoffen
DE69513307D1 (de) Zusammensetzung und verwendung
ATA11989A (de) Mittel zur vorbeugung gegen und behandlung von parodontopathien
ATE215373T1 (de) 21-hydro-6,19-oxidoprogesterone (21oh-60p) und deren verwendung als arzneimittel zur behandlung von glukokortikoidüberschuss
DE69900703D1 (de) Kosmetische Zusammensetzung enthaltend ein Polyorganosiloxan und ein Acrylterpolymer und Verwendung dieser Zusammensetzung zur Behandlung von Keratinmaterial
DE69734296D1 (de) Neue dikaffeoylchinasäurederivate und deren verwendung zur behandlung von hepatitis b
DE69426848T2 (de) Gerät zur Behandlung von lichtempfindlichen Materialien
DE69727240D1 (de) Kombinationen enthaltend vx478, zidovudin und 3tc zur behandlung von hiv
DE60027429D1 (de) Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien
DE69534371D1 (de) Wachstumsfaktoren enthaldende therapeutische homöopathische verdünnungen und verwendung
DE69624214D1 (de) Hormonale medikamente und deren verwendung zur behebung von östrogenmangelerscheinungen
DE69912670D1 (de) Substituierte tricyclische Verbindungen und deren Verwendung zur Behandlung von sPLA2-bedingten Erkrankungen
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen
DE69625883D1 (de) Zusammensetzung zur Reinigung und/oder Desinfektion von medizinischen Geräten
DE69418931T2 (de) Verwendung von VIP und deren Analogen und Fragmenten zur Behandlung von neurodegenerativen Krankheiten
ATE346840T1 (de) Aminoalkylphenol-derivate zur behandlung von depression und gedächtnis-funktionsstörung
DE3586420D1 (de) Verwendung von dihydropyridinen zur behandlung und praevention von arteriosklerose.

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication of lapse of patent is to be deleted
8364 No opposition during term of opposition